Welcome to NDF Research
  • Introducing NDF
  • About us
    • About our Senior Analyst
    • Disclaimer relating to research and web content
    • Financial Services Guide and General Advice Warning
  • What we do
    • The Rise of the New Analysts
    • MiFID II
  • Our sector
    • ASX-Listed Life Science companies we watch >
      • ASX-listed Life Science companies, >$200m
      • ASX-listed Life Science companies, $100-200m
    • About Australia and Australians
    • Australia and the Life Sciences
    • Life Sciences in New Zealand >
      • Building the New Zealand Life Sciences sector
    • A tour of Life Sciences Down Under
    • Australia's global competitiveness in Life Sciences >
      • Australia's Life Sciences Innovation Rating
      • Australia's Life Sciences clusters
      • Australia's World-Class Universities
      • Australia's Nobel Laureates
      • Australia's public policy support for Life Sciences
      • Australia's support for women in Life Sciences
    • The Coming Boom in Australian Life Sciences >
      • Welcome to Australia's Life Sciences Boom
    • Key organisations in the Life Science sector in Australia and New Zealand
    • Notable people in the Life Sciences sector in Australia and New Zealand >
      • Great CEOs
      • 2017 Red Hat Award Winners
      • 2018 Red Hat Award Winners
      • 2019 Red Hat Award Winners
    • The NDF Life Sciences Index >
      • 2016-2017 Year in Review
  • Our clients
  • Contact us
    • linkedin
    • Twitter
    • NDF Research Youtube Channel
  • Latest research
    • Comprehensive update reports
    • Shorter update reports
    • Initiation reports >
      • Admedus
      • Invion
    • Media and interviews
    • Presentations
    • Previous research and media, 2003-2015
    • A Brief History of the Life Sciences in Australia
    • In our library
    • Intellectual property >
      • Australian PCT patent applications
      • New Zealand PCT patent applications
      • PCT patent applications, last twelve months >
        • 2017 PCT patent applications
        • 2016 PCT patent applications
        • 2015 PCT patent applications
        • 2014 PCT patent applications
        • 2013 PCT patent applications
      • US patents >
        • 2017 US patents
        • 2016 US patents
        • 2015 US patents
        • 2014 US patents
    • Publications
    • Glossary
    • Global Life Science companies to watch
  • Blog
122 ASX-Listed Life Science companies to watch
By Stuart Roberts, Senior Analyst, stuart@ndfresearch.com, +61 447 247 909, (6 April 2018)
Here is a list of 123 emerging and established Life Science companies that we keep track of. Those with an asterisk next to their name are companies that Stuart Roberts covered either at Southern Cross Equities / Bell Potter or at Baillieu Holst.
Picture
Acrux (Melbourne, ASX: ACR, www.acrux.com.au) is a transdermal drug delivery company.
Picture
Actinogen Medical (Sydney,  ASX: ACW, www.actinogen.com.au) is an Alzheimer's  drug developer.​
Picture
AdAlta (Melbourne, ASX: 1AD, www.adalta.com.au) is pioneering 'i-bodies' originally inspired by shark antibodies, with an  initial focus on treating fibrotic diseases.
Picture
Adherium (Auckland, NZ, ASX: ADR, www.adherium.com). Developed the 'Smartinhaler', which tracks asthma medication compliance.
Picture
Admedus* (Brisbane, ASX: AHZ, www.admedus.com). Developer of tissue preparation and vaccine technology
Picture
AFT Pharmaceuticals (Auckland, NZ, ASX: AFP, www.aftpharm.com) manufactures various Rx and OTC products.
Picture
AirXpanders (Palo, Alto, Ca., ASX: AXP, www.airxpanders.com​) is commercialising a tissue expander system for breast reconstruction.
Picture
Alcidion (Adelaide, ASX: ALC, www.alcidion.com.au) is a health informatics company.
Picture
Allegra Orthopaedics (Sydney, ASX: AMT, www.allegraorthopaedics.com) is a manufacturer of prosthetic implants.
Picture
Analytica (Brisbane, ASX: ALT, www.analyticamedical.com) is the developer of a device to treat stress urinary incontinence.
Picture
Anatara Lifesciences (Brisbane, ASX: ANR, www.anataralifesciences.com) develops oral solutions for gastrointestinal diseases.
Picture
Anteo Diagnostics* (Sydney, ASX: ADO, www.anteodx.com) is a surface design technology play, initially focused in diagnostics.
Picture
Antisense Therapeutics (Melbourne, ASX: ANP, www.antisense.com.au) is a gene modification technology developer.
Picture
AtCor Medical (Sydney and Itasca, Il., ASX: ACG, www.atcormedical.com) is a developer of blood pressure diagnostic systems.
Picture
AusCann (Perth,  ASX: AC8,  www.auscann.com.au) is a medicinal cannabis company.
Picture
Avita Medical (Northridge, Ca., ASX: AVH, www.avitamedical.com) is developing 'spray-on skin'.
Picture
Bard1 Life Sciences (Perth, ASX: BD1, www.bard1.com) is developing a lung cancer diagnostic that works by identifying the cancer biomarker Bard1.
Picture
Benitec Biopharma (Sydney, ASX: BLT, www.benitec.com) is a gene silencing technology developer.
Picture
Bionomics* (Adelaide, ASX: BNO, www.bionomics.com.au) is a drug design house.
Picture
Biotron* (Sydney, ASX: BIT, www.biotron.com.au) is an anti-viral drug developer.
Picture
Bioxyne (Sydney, ASX: BXN, www.bioxyne.com) is a  developer of probiotics.
Picture
BLIS Technologies (Dunedin, New Zealand, NZX: BLT, www.blisprobiotic.com) is a  developer of probiotics.
Picture
Botanix Pharmaceuticals (Radnor, Pa., ASX: BOT, www.botanixpharma.com) is a developer of cannabinoid-based therapeutics for skin diseases.
Picture
Brain Resource* (Sydney, ASX: BRC, www.brainresource.com) is the owner of the world's largest brain function database.
Picture
Cellmid* (Sydney, ASX: CDY, www.cellmid.com.au) is working on drugs that target midkine, a heparin-binding growth factor.
Picture
Clinuvel Pharmaceuticals (Melbourne, ASX: CUV, www.clinuvel.com) develops of drugs to treat skin disorders.
Picture
Clover Corporation (Sydney, ASX: CLV, www.clovercorp.com.au) is a supplier of nutritional and functional ingredients for food.
Picture
Cochlear (Sydney, ASX: COH, www.cochlear.com) pioneered the cochlear implant which is routinely used these days to treat sensorineural hearing loss. 
Picture
Cogstate (Melbourne, ASX: CGS, www.cogstate.com) is a brain function company.
Picture
Compumedics (Melbourne, Australia, ASX: CMP, www.compumedics.com) is a developer of devices to measure brain function.
Picture
Creso Pharma (Perth, Australia, ASX: CPH, www.cresopharma.com.) is a medicinal cannabis company.
Picture
CSL Ltd (Melbourne, ASX: CSL, www.csl.com.au). This company, which originated as an entity owned by the Australian government called the Commonwealth Serum Laboratories, is today one of the 50 largest pharma companies in the world, with a franchise based on plasma products.
Picture
Cyclopharm (Sydney, ASX: CYC, www.cyclopharm.com.au) is a supplier of radiopharmaceuticals.
Picture
Cynata Therapeutics* (Melbourne, ASX: CYP, www.cynata.com) is a  stem cell company.
Picture
Dimerix (Perth, ASX: DXB, www.dimerix.com) is a developer of drugs that target G-protein coupled receptors, focused on kidney disorders.
Picture
dorsaVi (Melbourne, ASX: DVL, www.dorsavi.com) is a developer of orthopedic implants.
Picture
Ellex Medical Lasers (Adelaide, ASX: ELX, www.ellex.com) is a supplier of medical lasers for ophthalmology.
Picture
eSense-Lab (Ness Ziona, Israel, ASX: ESE, www.esense-lab.com) reverse engineers rare or lucrative plants in order to reconstruct their chemical profile and create alternate natural products.
Picture
EVE Investments (Perth, ASX: EVE, www.eveinvestments.com.au) is investing in Omniblend Innovation, a ​medical food technology company.
Picture
Factor Therapeutics* (Brisbane, ASX: FTT, www.factor-therapeutics.com) is a developer of wound healing technology.
Picture
Fisher & Paykel Healthcare* (Auckland, NZ, ASX: FPH, www.fphcare.com) supplies products and systems for use in respiratory care, acute care, and the treatment of obstructive sleep apnea.
Picture
Genera Biosystems (Melbourne, ASX: GBI, www.generabiosystems.com) is a  molecular diagnostics company.
Picture
Genetic Signatures (Sydney, ASX: GSS, www.geneticsignatures.com) develops of rapid PCR-based diagnostics.
Picture
Genetic Technologies (Melbourne, ASX: GTG, www.gtg.com.au) is monetising key patents over non-coding DNA.
Picture
GI Dynamics* (Lexington, Ma., ASX: GID, www.gidynamics.com) is the developer of a device to treat obesity and Type II diabetes.
Picture
Holista CollTech (Perth, Australia, ASX: HCT, www.holistaco.com) is a  collagen production technology company.
Picture
IDT Australia (Melbourne, ASX: IDT, www.idtaus.com.au) is a Contract Research Organisation.
Picture
Immuron (Melbourne, ASX: IMC, www.immuron.com) is a developer of dairy-derived polyclonal antibodies for immunotherapy.
Picture
Impedimed (Brisbane, and Carlsbad, Ca., ASX: IPD, www.impedimed.com.au) is commercialising a lymphedema diagnostic.
Picture
Imugene (Melbourne, ASX: IMU, www.imugene.com) is developing peptide vaccines for cancer immunotherapy.
Picture
Innate Immunotherapeutics (Auckland, NZ, ASX: IIL, www.innateimmunotherapeutics.com) is working an an MS treatment.
Picture
Invion (Brisbane, ASX: IVX, www.invion.com.au) is focused on repurposing of old drugs to treat respiratory disorders.
Picture
InvitroCue (Singapore, ASX: IVQ, www.invitrocue.com) is a provider of bioanalytics services.
Picture
Jayex Healthcare (Melbourne, Australia, ASX: JHL, www.jayexhealthcare.com.au) develops healthcare self-service solutions as well as software for patient flow management.
Picture
Kazia Therapeutics (Sydney, Australia, ASX: KZA, www.kaziatherapeutics.com) is developing a PI3K inhibitor for the treatment of glioblastoma.
Picture
LBT Innovations (Adelaide, ASX: LBT, www.lbtinnovations.com) develops automated solutions for microbiological culture. 
Picture
Leaf Resources (Perth, ASX: LER, www.leafresources.com.au) has technology to convert biomass into industrial sugars.
Picture
LifeHealthcare (Sydney, ASX: LHC, www.lifehealthcare.com.au) is a distributor of medical equipment.
Picture
Lifespot Health (Melbourne, Australia, ASX: LSH, www.lifespot-health.com) develops smartphone-based diagnostics.
Picture
Living Cell Technologies (Auckland, NZ, ASX: LCT, www.lctglobal.com). This xenotransplantation company focused on Parkinson's Disease.
Picture
Mach7 Technologies (Melbourne, ASX: M7T, www.mach7t.com) develops enterprise imaging solutions.
Picture
Mayne Pharma (Adelaide, ASX: MYX, www.maynepharma.com) is a generic drug company.
Picture
MedAdvisor (Melbourne, ASX: MDR, www.medadvisor.com.au). This company develops software helping pharmacists and doctors to remind patients when and how to take their medicines.
Picture
Medibio* (Sydney, ASX: MEB, www.medibio.com.au) is a developer of new mental health diagnostics.
Picture
Medical Developments (Melbourne, ASX: MVP, www.medicaldev.com) supplies the pain drug methoxyflurane.
Picture
Medlab Clinical (Sydney, ASX: MDC, www.medlab.co) is working on probiotic bacteria as well as nanotech-based drug delivery.
Picture
MGC Pharmaceuticals (Perth, ASX: MXC, www.mgcpharma.com.au) is a medical cannabis company.
Picture
Mesoblast* (Melbourne, ASX: MSB, www.mesoblast.com.au) is the world's leading stem cell company.
Picture
Micro-X (Adelaide, ASX: MX1, www.micro-x.com) is developing an ultra-lightweight medical x-ray.
Picture
MMJ Phytotech (Perth, ASX: MMJ,www.mmjphytotech.com.au) is a medical cannabis company.
Picture
Nanollose (Perth, ASX: NC6, www.nanollose.com) produces fibres using a fermentation process that provides an alternative to plant-derived cellulose fibres.
Picture
​Nanosonics (Sydney, ASX: NAN, www.nanosonics.com.au). This company's trophon EPR product disinfects ultrasound probes at low temperatures using ‘nanonebulant’ technology.
Picture
Neuren Pharmaceuticals* (Melbourne, ASX: NEU, www.neurenpharma.com) is a developer of neuroprotection drugs.
Picture
Neurotech International (Perth, ASX: NTI, www.neurotechinternational.com) develops neurofeedback systems for the home-based treatment of people with autism spectrum disorders.
Picture
Novita Healthcare (Melbourne, ASX: NHL, www.novitahealthcare.com.au) is working on a computerised program for improving childhood attention difficulties.
Picture
Noxopharm (Sydney, ASX: NOX, www.noxopharm.com) is a cancer drug developer.
Picture
Nuheara (Perth, ASX: NUH, www.nuheara.com) is a developer of intelligent hearing devices.
Picture
OBJ Ltd (Perth, ASX: OBJ, www.obj.com.au) is a transdermal drug delivery company.
Picture
OncoSil Medical* (Sydney, ASX: OSL, www.oncosil.com.au) is a developer of localised radiation therapy devices.
Picture
Opthea (Melbourne, ASX: OPT, www.opthea.com) is a developer of VEGF-blockers for the treatment of eye diseases.
Picture
Optiscan Imaging (Melbourne, ASX: OIL, www.opticsan.com) develops miniaturised confocal microscopes.
Picture
Orion Health (Auckland, NZ, ASX: OHE, www.orionhealth.com) is a developer of healthcare information technology.
Picture
Orthocell (Perth, ASX: OCC, www.orthocell.com.au) is a  stem cell company.
Picture
Osprey Medical (Eden Prairie, Mn., ASX: OSP, www.ospreymed.com) has developed a device to treat contract-induced nephropathy.
Picture
Oventus Medical (Brisbane, ASX: OVN, www.oventus.com) is developing a device for the treatment of sleep-disordered breathing.
Picture
Pacific Edge (Dunedin, NZ, NZX: PEB, www.pacificedge.co.nz) develops RNA-based cancer diagnostics.
Picture
PainChek (Sydney, ASX: PCK, www.painchek.com) is developing a mobile app that rapidly detects pain using facial recognition technology and smartphones. 
Picture
Paradigm Biopharma (Melbourne, ASX: PAR, www.paradigmbiopharma.com) is repurposing pentosan polysulphate sodium.
Picture
Patrys* (Sydney, ASX: PAB, www.patrys.com.au) is a cancer antibody drug developer.
Picture
PharmAust (Perth, ASX: PAA, www.pharmaust.com) is a cancer drug developer.
Picture
Pharmaxis (Sydney, ASX: PXS, www.pharmaxis.com.au) is a developer of drugs for respiratory diseases.
Picture
Phosphagenics* (Melbourne, ASX: POH, www.phosphagenics.com) is a transdermal drug delivery company.
Picture
Phylogica (Perth, ASX: PYC, www.phylogica.com.au) is a peptide drug discovery company.
Picture
PolyNovo (Melbourne, ASX: PNV, www.polynovo.com.au) is a developer of biodegradable polymer technology.
Picture
Prana Biotechnology* (Melbourne, ASX: PBT, www.pranabio.com) is an Alzheimer's drug developer.
Picture
Probiotec (Melbourne, ASX: PBP, www.probiotec.com.au) is a supplier of dietary supplements.
Picture
Proteomics International (Perth, ASX: PIQ, www.proteomics.com.au) is a provider of proteomics services that also works on biomarker discovery.
Picture
Promisia Integrative (Wellington, NZ, NZX: PIL, www.promisia.com) is a developer of dietary supplements.
Picture
RACE Oncology (Melbourne, ASX: RAC, www.raceoncology.com) is developing bisantrene for the treatment of Acute Myleoid Leukaemia.
Picture
Recce (Perth, ASX: RCE, www.recce.com.au) is a developer of new-generation antibiotics.
Picture
Regeneus (Sydney, ASX: RGS, www.regeneus.com.au) is a stem cell and cancer immunotherapy company.
Picture
ResApp Health (Perth, ASX: RAP, www.resapphealth.com.au) is a developer of a smartphone app for respiratory disease diagnosis. 
Picture
Resonance Health (Perth, ASX: RHT, www.resonancehealth.com) is developing FerriScan, widely recognised as the leading technology for  quantitative measurement of liver iron overload.
Picture
Respiri (Melbourne, ASX: RSH, www.respiri.co) is developing a lung function diagnostic.
Picture
REVA Medical* (San Diego, Ca., ASX: RVA, www.teamreva.com) is developing a bioresorbable stents.
Picture
Rhinomed* (Melbourne, ASX: RNO, www.rhinomed.com.au) is developing of a nasal device to improve upper airway patency.
Picture
Rhythm Biosciences (Melbourne, ASX: RHY, www.rhythmbio.com) is developing a blood test for colorectal cancer called ColoSTAT which assays a number of relevant biomarkers.
Picture
Sea Dragon (Nelson, NZ, NZX: SEA, www.seadragon.co.nz) is a producer of Omega-3 fish oil.
Picture
Sienna Cancer Diagnostics (Melbourne, ASX: SDX, www.siennadiagnostics.com.au) is a molecular diagnostics company.
Picture
Simavita (Sydney, ASX: SVA, www.simavita.com) has developed a medical device for urinary incontinence assessment and management.
Picture
SomnoMed (Sydney, ASX: SOM, www.somnomed.com) is a supplier of oral devices for the treatment of sleep apnea.
Picture
Starpharma* (Melbourne, ASX: SPL, www.starpharma.com) is commercialising a class of molecule called the dendrimer.
Picture
SUDA Pharmaceuticals (Perth, ASX: SUD, www.sudapharma.com) is a drug delivery company.
Picture
TBG Diagnostics (Melbourne, ASX: TDL, www.tbgbio.com) is a molecular diagnostics company.
Picture
The Hydroponics Company (Sydney, ASX: THC, www.thcl.com.au) is a medicinal cannabis company.
Picture
Universal Biosensors (Melbourne, ASX: UBI, www.universalbiosensors.com) is a diagnostics company.
Picture
Uscom (Sydney, ASX: UCM, www.uscom.com.au) is a developer of products to measure cardiovascular function.
Picture
Vectus Biosystems (Sydney, ASX: VBS, www.vectusbiosystems.com.au) is working on drugs to treat cardiovascular fibrosis and high blood pressure.
Picture
Visioneering Technologies (Alpharetta, Ga, ASX: VTI, www.vtivision.com​) develops products to treat eye conditions such as presbyopia, myopia and astigmatism.
Picture
Volpara Health Technologies (Wellington, New Zealand, ASX: VHT, www.volparasolutions.com) is developing a digital breast cancer diagnostic. 
Picture
Zelda Therapeutics (Perth, Australia, ASX: ZLD, www.zeldatherapeutics.com) is a medicinal cannabis company. 
Picture
Zoono (Auckland, NZ, ASX: ZNO,  www.zoono.com) is a developer of anti-microbial products. 

Copyright © 2018 NDF Research
Proudly powered by Weebly
  • Introducing NDF
  • About us
    • About our Senior Analyst
    • Disclaimer relating to research and web content
    • Financial Services Guide and General Advice Warning
  • What we do
    • The Rise of the New Analysts
    • MiFID II
  • Our sector
    • ASX-Listed Life Science companies we watch >
      • ASX-listed Life Science companies, >$200m
      • ASX-listed Life Science companies, $100-200m
    • About Australia and Australians
    • Australia and the Life Sciences
    • Life Sciences in New Zealand >
      • Building the New Zealand Life Sciences sector
    • A tour of Life Sciences Down Under
    • Australia's global competitiveness in Life Sciences >
      • Australia's Life Sciences Innovation Rating
      • Australia's Life Sciences clusters
      • Australia's World-Class Universities
      • Australia's Nobel Laureates
      • Australia's public policy support for Life Sciences
      • Australia's support for women in Life Sciences
    • The Coming Boom in Australian Life Sciences >
      • Welcome to Australia's Life Sciences Boom
    • Key organisations in the Life Science sector in Australia and New Zealand
    • Notable people in the Life Sciences sector in Australia and New Zealand >
      • Great CEOs
      • 2017 Red Hat Award Winners
      • 2018 Red Hat Award Winners
      • 2019 Red Hat Award Winners
    • The NDF Life Sciences Index >
      • 2016-2017 Year in Review
  • Our clients
  • Contact us
    • linkedin
    • Twitter
    • NDF Research Youtube Channel
  • Latest research
    • Comprehensive update reports
    • Shorter update reports
    • Initiation reports >
      • Admedus
      • Invion
    • Media and interviews
    • Presentations
    • Previous research and media, 2003-2015
    • A Brief History of the Life Sciences in Australia
    • In our library
    • Intellectual property >
      • Australian PCT patent applications
      • New Zealand PCT patent applications
      • PCT patent applications, last twelve months >
        • 2017 PCT patent applications
        • 2016 PCT patent applications
        • 2015 PCT patent applications
        • 2014 PCT patent applications
        • 2013 PCT patent applications
      • US patents >
        • 2017 US patents
        • 2016 US patents
        • 2015 US patents
        • 2014 US patents
    • Publications
    • Glossary
    • Global Life Science companies to watch
  • Blog